We do not intentionally collect and distribute personal data automatically from our website visitors. Those who submit comments have to give their email ids, which are not displayed or distributed to any third party. Subscription to future posts is through a Jetpack plugin, the data storing and emailing are through the plugin providers. Google will show only non-personalized ads to our users in the EEA as per the settings chosen by us. This is in order to minimize/eliminate privacy issues. Users who consider that data likely to be collected by Google is unacceptable, kindly do not continue on this site.

Changing over from Heparin to Warfarin

Changing over  from Heparin to Warfarin

Short Notes

Abstract: Heparin should be overlapped with warfarin till the INR is within therapeutic range, with a minimum of four days after initiation of warfarin therapy.

It is usual practice to start heparin initially and then switch over to warfarin in many situations like peripheral embolism and pulmonary embolism. Sometimes warfarin is not initiated along with heparin when potential for a surgical intervention is considered in the near future because of the longer wane out period of warfarin effect. When such a possibility does not exist, warfarin can be initiated along with heparin so that duration of heparin therapy can be minimised. It may be noted that longer duration of heparin therapy not only increases the cost and pain associated with injections, but also the chance of the rare heparin induced thrombocytopenia syndrome (HIT). When a longer duration of parenteral anticoagulation is expected, it may be better to initiate low molecular weight heparin (LMWH), which has a more predictable bioavailability.

The peak effect of a given dose of warfarin is reached in only about 96 hours, even if the INR (international normalized ratio of prothrombin time) is within the therapeutic range earlier than that. Hence a minimum heparin overlap period of four days is often considered mandatory while switching over from heparin to warfarin therapy. Once the suggested therapeutic range of INR for the thrombotic condition being treated is achieved, heparin can be discontinued, after a minimum period of four days.

Usual target INR is 2-3 in most cases. INR of 2.5-3.5 is recommended in those with mechanical prosthetic valve at mitral position as well as those who have gone aortic and mitral valve replacement. If it is only aortic mechanical prosthesis, target INR is 2-3.

MCQs in Medicine - Cardiovascular System is based on undergraduate medical curriculum. Though the questions are aimed at basic post graduate entrance examinations, candidates taking competitive exams at the post graduate exit level may also find them useful, especially the explanations for the answers. Undergraduate medical students will find them useful for answering MCQ tests in their regular exams. More than just answering MCQs, the explanations will improve the knowledge and understanding about the conditions discussed.Medicine MCQs - Cardiovascular System Kindle Edition: Click Here for a Preview Comments and suggestions are most welcome.